Experimental Evidence Reveals Both Cross-Infection and Cross-Contamination Risk of Embryo Storage in Liquid Nitrogen Biobanks.
In latest many years, gamete and embryo cryopreservation have turn into routine procedures in livestock and human assisted replica. However, the secure storage of germplasm and the prevention of illness transmission proceed to be potential hazards of illness transmission by way of embryo switch. This research aimed to display the potential danger of cross-infection of embryos from contaminated liquid nitrogen, and cross-contamination of sterile liquid nitrogen from contaminated embryos in bare and closed units. Additionally, we examined the results of antibiotic-free media on tradition growth of contaminated embryos.
The research was a laboratory-based evaluation utilizing rabbit as a mannequin. Two experiments have been carried out to judge each cross-infection (liquid nitrogen to embryos) and cross-contamination (embryos to liquid nitrogen) of artificially inoculated Salmonella Typhimurium, Staphylococcus aureus, Enterobacter aerogenes, and Aspergillus brasiliensis. Rapid cooling by way of vitrification was carried out on rabbit embryos, saved for a yr, thawed, and cultured. In vivo produced late morulae-early blastocyst phases (72 h) embryos have been used (n = 480). Embryos have been cultured for 1 h in options with and with out pathogens. Then, the embryos have been vitrified and saved in bare and closed units for one yr in two liquid nitrogen biobanks (one pathogen-free and the opposite artificially contaminated).
Embryos have been warmed and cultured for an additional 48 h, assessing the event and the presence of microorganism (chromogenic media, scanning electron microscopy). Embryos saved in bare units in artificially contaminated liquid nitrogen grew to become contaminated (12.5%), whereas not one of the embryos saved in closed units have been contaminated. Meanwhile, storage of artificially contaminated embryos incurred liquid nitrogen biobank contamination (100%). Observations by scanning electron microscopy revealed that each one the microorganisms have been caught within the floor of embryos after the vitrification-thawed process.
Nevertheless, embryos cultured in antibiotics and antimycotic medium developed to the hatched blastocyst stage, whereas artificially contaminated embryos cultured in antibiotic-free medium didn’t develop. In conclusion, our findings help that each cross-contamination and cross-infection throughout embryo storage in liquid nitrogen biobanks are believable. So, to make sure biosafety for the cryogenic storage, closed techniques that keep away from direct contact with liquid nitrogen should be used. Moreover, it appears important to offer greatest observe pointers for the cryogenic preservation and storage of gametes and embryos, to outline acceptable high quality and danger administration procedures.
Experimental Evidence Reveals Both Cross-Infection and Cross-Contamination Risk of Embryo Storage in Liquid Nitrogen Biobanks.
Graphdiyne nanoradioprotector with environment friendly free radical scavenging skill for mitigating radiation-induced gastrointestinal tract harm.
X-ray irradiation-induced toxicity to gastrointestinal tract turn into a big scientific downside when utilizing radiotherapy for treating belly tumors neighbored to gastrointestinal tissue, which not solely usually prevents these tumors from receiving a definitive therapeutic dose but additionally causes a collection of gastrointestinal illnesses, similar to anorexia, belly ache, diarrhea and hematochezia.
And thus it critically reduces the therapeutic consequence and life high quality of sufferers. Therefore, the event of gastrointestinal radioprotectors is important. However, the business gastrointestinal radioprotectors in scientific are nonetheless uncommon. In view of this, we ready bovine serum albumin (BSA) modified graphdiyne (GDY) nanoparticles (GDY-BSA NPs) and for the primary time studied its gastrointestinal radioprotection skill.
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-PLGF . This antibody is tested and proven to work in the following applications:
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: Placental growth factor (PGF) is also known as vascular endothelial growth factor-related protein, PLGF and PlGF2, is a member of the VEGF (vascular endothelial growth factor) sub-family - a key molecule in angiogenesis and vasculogenesis, in particular during embryogenesis. The main source of PGF during pregnancy is the placental trophoblast. PGF is also expressed in many other tissues, including the villous trophoblast. PGF is actived in angiogenesis and endothelial cell growth, stimulating their proliferation and migration. PlGF2 binds NRP1/neuropilin-1 and NRP2/neuropilin-2 in a heparin-dependent manner. Also promotes cell tumor growth.
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PlGF . This antibody is tested and proven to work in the following applications:
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PLGF in samples from serum, plasma, tissue homogenates and other biological fluids.
Description: Description of target: The protein, also called PGF, is 149 amino acids long and shares 53% identity with the platelet-derived growth factor-like region of human VPF. And the N-glycosylated PLGF protein is secreted into the medium and that it functions as a dimer1. The PLGF gene is mapped to 14q24-q31. There are 3 isoforms of PGF, designated PGF1, PGF2, and PGF3. Only PGF2 is able to bind heparin. Additionally, PGF regulates inter- and intramolecular cross-talk between the VEGF receptor tyrosine kinases FLT1 and FLK12. It also can stimulate angiogenesis and collateral growth in ischemic heart and limb with at least a comparable efficiency to VEGF3.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 1 pg/mL
Description: Placenta Growth Factor-2 (PLGF-2) is an angiogenic factor produced in umbilical vein endothelial cells and placenta. PLGF-2 plays important roles in angiogenesis and endothelial cell growth.
Description: Placenta Growth Factor-2 (PLGF-2) is an angiogenic factor produced in umbilical vein endothelial cells and placenta. PLGF-2 plays important roles in angiogenesis and endothelial cell growth.
Description: Placenta Growth Factor-2 (PLGF-2) is an angiogenic factor produced in umbilical vein endothelial cells and placenta. PLGF-2 plays important roles in angiogenesis and endothelial cell growth.
Description: PlGF-3 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-3 is expressed exclusively in the placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-3 lacks heparin binding affinity. Recombinant human PlGF-3 is a 45.7 kDa disulfide-linked homodimeric protein of two 203 amino acid polypeptide chains.
Description: PlGF-1 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-1 is expressed in placental tissues, colon and mammary carcinomas. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. Recombinant human PlGF-1 is a 29.7 kDa disulfide-linked homodimeric protein of two 132 amino acid polypeptide chains.
Description: PLGF-2 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PLGF-2 is expressed in umbilical vein endothelial cells and placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-2 also signals through Neuropilin (NP-1) and can bind with high affinity to heparin. Recombinant human PLGF-2 is a 34.0 kDa disulfide-linked homodimeric protein of two 150 amino acid polypeptide chains.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
×
The distinctive benefits of GDY nanomaterial, together with excessive free radical scavenging skill, good chemical stability in gastric acid situation, comparatively longer residence time in gastrointestinal tract and good biosafety underneath oral administration, present the favorable stipulations for it for use because the gastrointestinal radioprotector. In vitro experimental outcomes indicated that the GDY-BSA NPs powerfully diminished DNA harm and improved viability of the irradiated gastrointestinal cells. In vivo outcomes confirmed that the GDY-BSA NPs considerably lower radiation-induced diarrhea, weight reduction, and gastrointestinal tissue pathological harm of mice.
